Gainers
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) jumped 76% to $28.13 after the company's once-daily oral paltusotine achieved the primary and secondary endpoints in the Phase 3 PATHFNDR-1 study in acromegaly.
Carlisle Companies Incorporated (NYSE:CSL, the "Company")))) today announced that its Board of Directors approved a 13% increase in the Company's regular quarterly dividend from $0.75 to $0.85 per share, or to $3.40 per